Suppr超能文献

p53 Pro72Arg 多态性与非洲裔男性前列腺癌。

p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

机构信息

Howard University Cancer Center, College of Medicine, Washington, DC 20060, USA.

出版信息

Prostate. 2010 Dec 1;70(16):1739-45. doi: 10.1002/pros.21209.

Abstract

BACKGROUND

p53 is a transcription factor that regulates the cell cycle, DNA repair, and apoptosis. A variant at codon 72, rs1042522, results in altered activities for p53 and is, notably, differentially distributed among different ethnic populations. However, associations of this variant with cancer in men of African descent have not been explored. Herein, we tested the hypothesis that rs1042522 was associated with prostate cancer (PCa) risk.

MATERIALS AND METHODS

Genotypes were determined by PCR-RFLP methods in a study population of African descent consisting of 266 PCa patients and 196 male controls.

RESULTS

Our results indicate that the p53 polymorphism may be associated with increased risk of PCa. Genotypes were significantly and marginally associated with PCa risk using the dominant and log-additive genetic models (OR=1.53, 95% CI: 1.02-2.29, P=0.04; OR=1.33, 95% CI: 0.99-1.78, P=0.06, respectively). After adjusting for age, the associations with PCa remained, but results were not statistically significant (OR=1.48, 95% CI: 0.95-2.31, P=0.08; OR=1.30, 95% CI: 0.95-1.80, P=0.10, respectively).

CONCLUSIONS

The present study demonstrates that population-dependent differences in allele frequencies associated with health disparities provide a valuable framework for the interrogation of complex diseases in all populations.

摘要

背景

p53 是一种转录因子,可调节细胞周期、DNA 修复和细胞凋亡。密码子 72 处的变体 rs1042522 导致 p53 活性改变,并且在不同种族人群中的分布明显不同。然而,该变体与非洲裔男性癌症的相关性尚未得到探索。在此,我们检验了 rs1042522 与前列腺癌(PCa)风险相关的假设。

材料和方法

在一个由 266 名 PCa 患者和 196 名男性对照组成的非洲裔人群研究人群中,通过 PCR-RFLP 方法确定基因型。

结果

我们的结果表明,p53 多态性可能与 PCa 风险增加相关。使用显性和对数加性遗传模型,基因型与 PCa 风险显著相关(OR=1.53,95%CI:1.02-2.29,P=0.04;OR=1.33,95%CI:0.99-1.78,P=0.06)。在调整年龄后,与 PCa 的关联仍然存在,但结果无统计学意义(OR=1.48,95%CI:0.95-2.31,P=0.08;OR=1.30,95%CI:0.95-1.80,P=0.10)。

结论

本研究表明,与健康差异相关的等位基因频率的人群依赖性差异为所有人群中复杂疾病的研究提供了有价值的框架。

相似文献

1
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
Prostate. 2010 Dec 1;70(16):1739-45. doi: 10.1002/pros.21209.
5
Association of CD14 variant with prostate cancer in African American men.
Prostate. 2010 Feb 15;70(3):262-9. doi: 10.1002/pros.21060.
7
Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese.
Cancer Genet Cytogenet. 2010 Oct 15;202(2):76-81. doi: 10.1016/j.cancergencyto.2010.02.014.

引用本文的文献

2
Genetic and biological drivers of prostate cancer disparities in Black men.
Nat Rev Urol. 2024 May;21(5):274-289. doi: 10.1038/s41585-023-00828-w. Epub 2023 Nov 14.
3
Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children.
Mol Biol Rep. 2022 Sep;49(9):8291-8300. doi: 10.1007/s11033-022-07643-3. Epub 2022 Jun 15.
4
Intronic Polymorphisms Are Associated with Increased Transcript, Immune Infiltration and Cancer Risk.
Cancers (Basel). 2020 Sep 1;12(9):2472. doi: 10.3390/cancers12092472.
5
Polymorphism of glutathione S-transferase in the population of Polish patients with carcinoma of the prostate.
Environ Sci Pollut Res Int. 2020 Jun;27(16):19375-19382. doi: 10.1007/s11356-020-08435-7. Epub 2020 Mar 24.
6
Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis.
Medicine (Baltimore). 2019 Jun;98(25):e16135. doi: 10.1097/MD.0000000000016135.
7
Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer.
J Cancer. 2018 Jun 4;9(12):2191-2202. doi: 10.7150/jca.22846. eCollection 2018.
8
Association between the rs1042522 polymorphism in and prostate cancer risk: An updated meta-analysis.
Chronic Dis Transl Med. 2017 May 25;3(2):95-104. doi: 10.1016/j.cdtm.2017.04.001. eCollection 2017 Jun 25.
9
Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
PLoS One. 2017 Oct 19;12(10):e0186190. doi: 10.1371/journal.pone.0186190. eCollection 2017.
10
Association of and polymorphisms with prostate cancer.
Biomed Rep. 2015 Sep;3(5):707-714. doi: 10.3892/br.2015.496. Epub 2015 Jul 27.

本文引用的文献

1
Adaptive evolution of p53 thermodynamic stability.
J Mol Biol. 2009 Oct 16;393(1):161-75. doi: 10.1016/j.jmb.2009.08.013. Epub 2009 Aug 13.
2
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.
Lancet Oncol. 2009 Aug;10(8):772-84. doi: 10.1016/S1470-2045(09)70187-1. Epub 2009 Jul 20.
3
Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia.
Am J Hum Genet. 2009 Apr;84(4):534-41. doi: 10.1016/j.ajhg.2009.03.009. Epub 2009 Apr 2.
4
Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.
Clin Cancer Res. 2009 Apr 1;15(7):2406-16. doi: 10.1158/1078-0432.CCR-08-1719.
5
Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.
Gynecol Oncol. 2009 Apr;113(1):109-14. doi: 10.1016/j.ygyno.2008.12.036. Epub 2009 Feb 3.
6
p53 polymorphisms: cancer implications.
Nat Rev Cancer. 2009 Feb;9(2):95-107. doi: 10.1038/nrc2584.
7
p53 regulates maternal reproduction through LIF.
Nature. 2007 Nov 29;450(7170):721-4. doi: 10.1038/nature05993.
10
Polymorphisms of DNA repair genes are risk factors for prostate cancer.
Eur J Cancer. 2007 Jan;43(2):231-7. doi: 10.1016/j.ejca.2006.11.005. Epub 2006 Dec 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验